PSTX - Poseida Therapeutics
Earnings Results
Results > Poseida Therapeutics - PSTX >
Notice: Undefined variable: result_year in F:\Web_apps\web\earnings-ahead\results\single.php on line 197

Poseida Therapeutics ( $PSTX )

Recent earnings result

  1. Poseida Therapeutics EPS misses by $1.13

Top Stories (PSTX)

Events & Annual meetings

There are no events at this time for this stock.


For list of PSTX events, you may visit their Investor Relations website.




Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing our proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure. We have discovered and are developing a broad portfolio of product candidates in a variety of indications based on our core proprietary platforms, including our non-viral piggyBac DNA Modification System, Cas-CLOVER site-specific gene editing system and nanoparticle- and AAV-based gene delivery technologies. Our core platform technologies have utility, either alone or in combination, across many cell and gene therapeutic modalities and enable us to engineer our wholly-owned portfolio of product candidates that are designed to overcome the primary limitations of current generation cell and gene therapeutics.


For list of PSTX events, you may visit their Investor Relations website.

Recent results

Books we are reading